.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Moodys
Chubb
UBS
Cantor Fitzgerald
Medtronic
QuintilesIMS
US Department of Justice
Harvard Business School
Argus Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Ranbaxy Company Profile

« Back to Dashboard

What is the competitive landscape for RANBAXY, and what generic and branded alternatives to RANBAXY drugs are available?

RANBAXY has fifty-three approved drugs.

There are seventeen tentative approvals on RANBAXY drugs.

Summary for Ranbaxy

US Patents:0
Tradenames:38
Ingredients:35
NDAs:53
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
RanbaxyCEFACLORcefaclorFOR SUSPENSION;ORAL064155-001Oct 2, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL076445-002Apr 23, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL076445-003Apr 23, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdCEFUROXIME AXETILcefuroxime axetilTABLET;ORAL065043-001Feb 15, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
RanbaxyAVENTYL nortriptyline hydrochlorideSOLUTION;ORAL014685-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
RanbaxyRANITIDINE HYDROCHLORIDEranitidine hydrochlorideSYRUP;ORAL078448-001Dec 13, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL076445-004Apr 23, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdGANCICLOVIRganciclovirCAPSULE;ORAL076457-002Jun 27, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdFOSINOPRIL SODIUMfosinopril sodiumTABLET;ORAL076580-001Apr 23, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdRANICLORcefaclorTABLET, CHEWABLE;ORAL065092-001Dec 22, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Ranbaxy

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
RanbaxyLAC-HYDRINammonium lactateLOTION;TOPICAL019155-001Apr 24, 1985► Subscribe► Subscribe
RanbaxyAVENTYL nortriptyline hydrochlorideSOLUTION;ORAL014685-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
RanbaxyULTRAVATEhalobetasol propionateOINTMENT;TOPICAL019968-001Dec 17, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Teva
Baxter
Express Scripts
McKesson
Julphar
Chubb
Chinese Patent Office
US Department of Justice
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot